Company

Aviko Radiopharmaceuticals

Biotechnology Research New York, Ny, United States 10 employees

Employees: 10
Contacts: 3
Emails: 3
Phones: 1

avikobnct.com LinkedIn

Aviko Radiopharmaceuticals Overview

Headquarters: New York, Ny, United States
Website: avikobnct.com
Industry: Biotechnology Research
Employees: 10
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

New York

About Aviko Radiopharmaceuticals

Aviko Radiopharmaceuticals is a privately held biotechnology company developing medicines to unlock the potential of boron neutron capture therapy (BNCT) to treat a wide variety of cancers. Aviko’s innovative compounds are designed to improve the efficacy of BNCT by targeting and delivering boron to cancer cells with precision. Together with their partners, Aviko is advancing BNCT as a safe, efficacious and convenient treatment modality for patients. Founded by Deerfield Management, Aviko is based at Cure., a healthcare innovation campus in New York City.

Aviko Radiopharmaceuticals Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage
Phone contacts: 1; 33.3% coverage

Aviko Radiopharmaceuticals Org Chart

Sample employees and titles

Name	Title	Location	Contact
Ming Lu	Associate Vice President, Imaging	Aberdeen, Maryland, United States	Email Phone
David Turner	Chief Operating Officer at Innervate	Englewood, New Jersey, United States	Email
David Tischler	Biotech Executive - Entrepreneur	San Francisco, California, United States	Email